Asymmetry Capital Management, L.P. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2019$1,875,000
-44.7%
47,453
-42.5%
4.02%
+119.0%
Q2 2019$3,388,000
+141.5%
82,473
+173.8%
1.84%
-21.7%
Q1 2019$1,403,000
+73.6%
30,125
+62.3%
2.34%
+5.0%
Q4 2018$808,000
-64.6%
18,564
-53.5%
2.23%
+5.8%
Q3 2018$2,284,000
+108.6%
39,912
+76.9%
2.11%
+95.9%
Q2 2018$1,095,00022,5581.08%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$00.00%
View complete list of ACCELERON PHARMA INC shareholders